Sinus Lift With Newly Forming Bone and Inorganic Bovine Bone
NCT ID: NCT03419338
Last Updated: 2018-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2010-03-01
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness in Limiting the Need to Elevate the Maxillary Sinus
NCT03357705
Radiographic and Histomorphometric Assessment for Maxillary Sinus Floor Elevation and Augmentation Using A Mixture of 1:1 Autogenous Bone With Deproteinized Bovine Bone Particulate Versus Deproteinized Bovine Bone Particulate
NCT07177495
PRF Versus Advanced PRF in Sinus Augmentation
NCT05134753
Maxillary Sinus Augmentation With Xenogeneic Bone Graft Associated or Not With Fibrin Rich in Platelets and Leukocytes Produced by Horizontal Centrifugation: A Randomized Clinical Trial.
NCT05957705
The Use of Extended Platelet Rich Fibrin in Lateral Sinus Augmentation
NCT06626776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test group
Surgical alveolus + maxillary sinus lift with inorganic bovine bone + newly forming bone + collagen membrane
Sinus lift
Using a lateral access, the Schneider membrane will be elevated using curettes allowing the insertion of graft material.
Surgical alveolus
Using a round diamond bur, a surgical alveolus will be created on an toothless ridge region.
Inorganic bovine bone + newly forming bone
Maxillary sinus lift will be done with inorganic bovine bone associated with newly forming bone. The newly forming bone will be collected from surgical alveolus previous prepared.
Collagen membrane
At the end of the sinus lift, a collagen membrane will be used to obliterate the graft inside the maxillary sinus.
Control group
Maxillary sinus lift with inorganic bovine bone + collagen membrane
Sinus lift
Using a lateral access, the Schneider membrane will be elevated using curettes allowing the insertion of graft material.
Inorganic bovine bone
Maxillary sinus lift will be done with inorganic bovine bone.
Collagen membrane
At the end of the sinus lift, a collagen membrane will be used to obliterate the graft inside the maxillary sinus.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sinus lift
Using a lateral access, the Schneider membrane will be elevated using curettes allowing the insertion of graft material.
Surgical alveolus
Using a round diamond bur, a surgical alveolus will be created on an toothless ridge region.
Inorganic bovine bone + newly forming bone
Maxillary sinus lift will be done with inorganic bovine bone associated with newly forming bone. The newly forming bone will be collected from surgical alveolus previous prepared.
Inorganic bovine bone
Maxillary sinus lift will be done with inorganic bovine bone.
Collagen membrane
At the end of the sinus lift, a collagen membrane will be used to obliterate the graft inside the maxillary sinus.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Use of drugs that affect periodontal tissues (eg: anticonvulsants, calcium channel blockers, cyclosporine, bisphosphonates, hormone-based, contraceptives, steroids)
* Pregnant
* Smokers
* Diabetics
* History of head and neck radiotherapy
25 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adriana Campos Passanezi SantAna
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adriana CP Sant'Ana, PhD
Role: PRINCIPAL_INVESTIGATOR
Bauru School of Dentistry - University of Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bauru School of Dentistry - University of Sao Paulo
Bauru, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FOBGranSinus
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.